Innovative Biosensing Technologies for Sustainable Healthcare

A special issue of Biosensors (ISSN 2079-6374). This special issue belongs to the section "Biosensor and Bioelectronic Devices".

Deadline for manuscript submissions: 31 May 2025 | Viewed by 3343

Special Issue Editors


E-Mail Website
Guest Editor
School of Mechanical & Aerospace Engineering, Nanyang Technological University, 50 Nanyang Avenue, Singapore 639798, Singapore
Interests: modeling of smart hydrogels for bioMMS applications
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
School of Mechanical & Aerospace Engineering, Nanyang Technological University, Singapore, Singapore
Interests: fracture; soft matter; hydrogel; smart hydrogel in bioMEMS and biological cell in microscale fields

Special Issue Information

Dear Colleagues,

This Special Issue is dedicated to exploring advanced biosensing technologies designed specifically for monitoring and managing chronic diseases within sustainable healthcare frameworks. It seeks to highlight the latest research and development in biosensors that are tailor made for long-term disease management, from conceptualization and modeling to experimental validation and real-world applications. We focus particularly on novel materials and innovative device designs that offer new insights into patient health and disease progression, contributing to improved patient outcomes and reduced environmental impact. Contributions that demonstrate theoretical analyses and laboratory and field studies, and especially those that show potential for practical feasibility and commercialization in chronic disease contexts, are highly encouraged.

Prof. Dr. Hua Li
Dr. Shoujing Zheng
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biosensors is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • sustainability
  • healthcare
  • biosensor
  • bioactuator
  • biorobot
  • rehabilitation
  • smart biomaterials
  • healthcare device/system
  • green biomaterials
  • smart biotechnology

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Review

55 pages, 6871 KiB  
Review
Recent Progress in Biosensors for Depression Monitoring—Advancing Personalized Treatment
by Jiaju Yin, Xinyuan Jia, Haorong Li, Bingchen Zhao, Yi Yang and Tian-Ling Ren
Biosensors 2024, 14(9), 422; https://doi.org/10.3390/bios14090422 - 30 Aug 2024
Viewed by 1846
Abstract
Depression is currently a major contributor to unnatural deaths and the healthcare burden globally, and a patient’s battle with depression is often a long one. Because the causes, symptoms, and effects of medications are complex and highly individualized, early identification and personalized treatment [...] Read more.
Depression is currently a major contributor to unnatural deaths and the healthcare burden globally, and a patient’s battle with depression is often a long one. Because the causes, symptoms, and effects of medications are complex and highly individualized, early identification and personalized treatment of depression are key to improving treatment outcomes. The development of wearable electronics, machine learning, and other technologies in recent years has provided more possibilities for the realization of this goal. Conducting regular monitoring through biosensing technology allows for a more comprehensive and objective analysis than previous self-evaluations. This includes identifying depressive episodes, distinguishing somatization symptoms, analyzing etiology, and evaluating the effectiveness of treatment programs. This review summarizes recent research on biosensing technologies for depression. Special attention is given to technologies that can be portable or wearable, with the potential to enable patient use outside of the hospital, for long periods. Full article
(This article belongs to the Special Issue Innovative Biosensing Technologies for Sustainable Healthcare)
Show Figures

Figure 1

22 pages, 3860 KiB  
Review
Recent Developments in Personal Glucose Meters as Point-of-Care Testing Devices (2020–2024)
by Dan-Ni Yang, Shan Geng, Rong Jing and Hao Zhang
Biosensors 2024, 14(9), 419; https://doi.org/10.3390/bios14090419 - 27 Aug 2024
Viewed by 1172
Abstract
Point-of-care testing (POCT) is a contemporary diagnostic approach characterized by its user-friendly nature, cost efficiency, environmental compatibility, and lack of reliance on professional experts. Therefore, it is widely used in clinical diagnosis and other analytical testing fields to meet the demand for rapid [...] Read more.
Point-of-care testing (POCT) is a contemporary diagnostic approach characterized by its user-friendly nature, cost efficiency, environmental compatibility, and lack of reliance on professional experts. Therefore, it is widely used in clinical diagnosis and other analytical testing fields to meet the demand for rapid and convenient testing. The application of POCT technology not only improves testing efficiency, but also brings convenience and benefits to the healthcare industry. The personal glucose meter (PGM) is a highly successful commercial POCT tool that has been widely used not only for glucose analysis, but also for non-glucose target detection. In this review, the recent advances from 2020 to 2024 in non-glucose target analysis for PGMs as POCT devices are summarized. The signal transduction strategies for non-glucose target analysis based on PGMs, including enzymatic transduction, nanocarrier transduction (enzyme or glucose), and glucose consumption transduction are briefly introduced. Meanwhile, the applications of PGMs in non-glucose target analysis are outlined, encompassing biomedical, environmental, and food analysis, along with other diverse applications. Finally, the prospects of and obstacles to employing PGMs as POCT tools for non-glucose target analysis are discussed. Full article
(This article belongs to the Special Issue Innovative Biosensing Technologies for Sustainable Healthcare)
Show Figures

Figure 1

Back to TopTop